John Lewicki

9.2k total citations · 3 hit papers
94 papers, 6.9k citations indexed

About

John Lewicki is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John Lewicki has authored 94 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 34 papers in Oncology and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John Lewicki's work include Cancer Cells and Metastasis (19 papers), Heart Failure Treatment and Management (13 papers) and Receptor Mechanisms and Signaling (13 papers). John Lewicki is often cited by papers focused on Cancer Cells and Metastasis (19 papers), Heart Failure Treatment and Management (13 papers) and Receptor Mechanisms and Signaling (13 papers). John Lewicki collaborates with scholars based in United States, Australia and Canada. John Lewicki's co-authors include Robert M. Scarborough, Thomas Maack, Austin Gurney, Glenn McEnroe, Daniel R. Nussenzveig, Michael F. Clarke, Timothy Hoey, Dale B. Schenk, J G Porter and Xinhao Wang and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

John Lewicki

93 papers receiving 6.5k citations

Hit Papers

Physiological Role of Sil... 1987 2026 2000 2013 1987 2007 1988 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John Lewicki 3.6k 2.6k 2.0k 814 773 94 6.9k
Seiji Takashima 3.6k 1.0× 2.1k 0.8× 1.0k 0.5× 273 0.3× 523 0.7× 166 7.6k
Ross D. Hannan 6.4k 1.8× 950 0.4× 1.4k 0.7× 455 0.6× 833 1.1× 151 8.6k
Sylvain Meloche 7.3k 2.0× 1.2k 0.5× 1.9k 1.0× 555 0.7× 1.3k 1.7× 151 10.6k
Lei Wei 4.3k 1.2× 1.1k 0.4× 834 0.4× 254 0.3× 535 0.7× 103 6.4k
Marco Castagna 3.4k 0.9× 1.1k 0.4× 496 0.3× 702 0.9× 447 0.6× 68 6.3k
Randal A. Skidgel 2.7k 0.7× 1.5k 0.6× 1.8k 0.9× 381 0.5× 329 0.4× 120 6.5k
Anton Wellstein 6.1k 1.7× 524 0.2× 2.1k 1.1× 803 1.0× 1.6k 2.1× 223 9.4k
Yoon S. Cho‐Chung 4.1k 1.1× 670 0.3× 1.9k 0.9× 464 0.6× 620 0.8× 159 6.4k
Marie A. Bogoyevitch 5.2k 1.4× 1.5k 0.6× 861 0.4× 197 0.2× 591 0.8× 109 7.5k
Yoshiyuki Rikitake 3.3k 0.9× 1.1k 0.4× 577 0.3× 510 0.6× 697 0.9× 111 6.2k

Countries citing papers authored by John Lewicki

Since Specialization
Citations

This map shows the geographic impact of John Lewicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lewicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lewicki more than expected).

Fields of papers citing papers by John Lewicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lewicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lewicki. The network helps show where John Lewicki may publish in the future.

Co-authorship network of co-authors of John Lewicki

This figure shows the co-authorship network connecting the top 25 collaborators of John Lewicki. A scholar is included among the top collaborators of John Lewicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lewicki. John Lewicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Srivastava, Minu K., Erin Mayes, Christopher L. Murriel, et al.. (2017). Abstract 2003: Antibody against TIGIT (T cell immunoreceptor with Ig and ITIM domains) induces anti-tumor immune response and generates long-term immune memory. Cancer Research. 77(13_Supplement). 2003–2003. 8 indexed citations
2.
Yen, Wan-Ching, Marcus Fischer, Fumiko Axelrod, et al.. (2015). Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency. Clinical Cancer Research. 21(9). 2084–2095. 195 indexed citations
4.
Fischer, Marcus, Mark J. Hynes, Jingjiang Wu, et al.. (2012). Anti-DLL4 Has Broad Spectrum Activity in Pancreatic Cancer Dependent on Targeting DLL4-Notch Signaling in Both Tumor and Vasculature Cells. Clinical Cancer Research. 18(19). 5374–5386. 58 indexed citations
5.
Petrillo, Laura A., Denise M. Wolf, Ann M. Kapoun, et al.. (2012). Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors. Breast Cancer Research and Treatment. 135(3). 913–922. 31 indexed citations
6.
Fischer, Marcus, Wan-Ching Yen, Ann M. Kapoun, et al.. (2010). Anti-DLL4 Inhibits Growth and Reduces Tumor-Initiating Cell Frequency in Colorectal Tumors with Oncogenic KRAS Mutations. Cancer Research. 71(5). 1520–1525. 100 indexed citations
7.
Hoey, Timothy, Wan-Ching Yen, Fumiko Axelrod, et al.. (2009). DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency. Cell stem cell. 5(2). 168–177. 318 indexed citations
8.
Dylla, Scott J., Lucia Beviglia, In‐Kyung Park, et al.. (2008). Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy. PLoS ONE. 3(6). e2428–e2428. 448 indexed citations
9.
Liu, Rui, Xinhao Wang, Grace Chen, et al.. (2007). The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells. New England Journal of Medicine. 356(3). 217–226. 742 indexed citations breakdown →
10.
Mavunkel, Babu, Sarvajit Chakravarty, John Perumattam, et al.. (2003). Indole-based heterocyclic inhibitors of p38α MAP kinase: designing a conformationally restricted analogue. Bioorganic & Medicinal Chemistry Letters. 13(18). 3087–3090. 22 indexed citations
11.
O'Neal, DN, et al.. (1998). Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects. Atherosclerosis. 136(1). 1–8. 31 indexed citations
12.
Lewicki, John, et al.. (1996). [ACTIVITY OF ARYL SULFATASE IN THE BLOOD SERUM DURING THE COURSE OF PREGNANCY, LABOR AND PUERPERIUM].. PubMed. 34. 321–7.
13.
Okolicány, J, et al.. (1991). Effects of small C-ANF receptor ligands on plasma levels of atrial natriuretic factor, blood pressure, and renal function in the rat. Canadian Journal of Physiology and Pharmacology. 69(10). 1561–1566. 8 indexed citations
14.
Parkes, David G., J. P. Coghlan, John Lewicki, Robert M. Scarborough, & B. A. Scoggins. (1990). Hemodynamic Effects of Atrial Natriuretic Factor Clearance Receptor Occupancy in Conscious Sheep. American Journal of Hypertension. 3(11). 829–832. 2 indexed citations
15.
Porter, J. Gordon, et al.. (1990). Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA. Biochemical and Biophysical Research Communications. 171(2). 796–803. 94 indexed citations
16.
Seilhamer, Jeffrey J., Ann Arfsten, Judith Miller, et al.. (1989). Human and canine gene homologs of porcine brain natriuretic peptide. Biochemical and Biophysical Research Communications. 165(2). 650–658. 106 indexed citations
17.
Williams, Mary C., et al.. (1988). Monoclonal Antibodies to Surfactant Proteins SP28–36 Label Canine Type II and Nonciliated Bronchiolar Cells by Immunofluorescence. American Review of Respiratory Disease. 137(2). 399–405. 38 indexed citations
18.
Maack, Thomas, Muneya Suzuki, Fernando Antônio de Almeida, et al.. (1987). Physiological Role of Silent Receptors of Atrial Natriuretic Factor. Science. 238(4827). 675–678. 786 indexed citations breakdown →
19.
Lewicki, John, Bing Chang, & Ferid Murad. (1983). Quantification of guanylate cyclase concentrations by a direct double determinant tandem immunoradiometric assay.. Journal of Biological Chemistry. 258(6). 3509–3515. 11 indexed citations
20.
Waldman, Scott A., John Lewicki, Ling Chang, & Ferid Murad. (1983). Highly purified particulate guanylate cyclase from rat lung: characterization and comparison with soluble guanylate cyclase. Molecular and Cellular Biochemistry. 57(2). 155–166. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026